Arisaph Pharmaceuticals, Inc.
Arisaph Pharmaceuticals, Inc. is an emerging drug-discovery biopharmaceutical company focused on developing best-in-class drugs for cancer, cardiovascular disease and diabetes. The company utilizes proprietary drug discovery platforms to develop differentiated medicines that are highly potent and act on select targets. Arisaph currently has seven active drug discovery programs in various stages of preclinical development. The company was founded in 1999 with the vision of becoming a fully-integrated Company, in which Arisaph not only develops its differentiated therapies but also commercializes such products through a specialty sales force and/or strategic corporate partnerships.Back to list